Suppression of BDNF-induced expression of neuropeptide Y (NPY) in cortical cultures by oxygen-glucose deprivation: A model system to study ischemic mechanisms in the perinatal brain

Journal of Neuroscience Research

Volumn 68, Issue 2, 2002, Pages 199-212

  Barnea, Ayalla ^a   Roberts, Jodie ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cell death; Fetal; Hypoxia; MAP 2; Neuron

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; NEUROPEPTIDE Y; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL AGGREGATION; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; IMMUNOHISTOCHEMISTRY; NERVE CELL; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL HYPOXIA; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO; FEMALE; GLUCOSE; NEURONS; NEUROPEPTIDE Y; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0036217857     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10191     Document Type: Article

References (82)

1. Does the onset of neonatal seizures correlate with the timing of fetal neurologic injury?
2. Neurochemical changes following occlusion of the middle cerebral artery in rats
3. Neuropeptide Y distribution in the rat brain
4. Activation of the human NPY gene during neuroblastoma cell differentiation: Induced transcriptional activities of AP-1 and AP-2
5. Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease
6. Predictive factors of early seizures after acute cerebrovascular disease
7. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y
8. Comparison of neurotrophin regulation of human and rat neuropeptide Y (NPY) neurons: Induction of NPY production in aggregate cultures derived from rat but not from human fetal brains
9. Morphological differentiation of neuropeptide Y neurons in aggregate cultures of dissociated fetal cortical cells: A model system for gila-neuron paracrine interactions
10. Brain-derived neurotrophic factor induces functional expression and phenotypic differentiation of cultured fetal neuropeptide Y producing neurons
11. Truncated insulin-like growth factor: A potent inducer of neuropeptide Y production by aggregate cultures of fetal brain cells
12. Regulated production and secretion of immunoreactive neuropeptide Y by aggregating fetal brain cells in culture
13. Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brain-derived neurotrophic factor (BDNF): Evidence for a requirement for extracellular-regulated kinase (ERK)-dependent and ERK-independent mechanisms
14. Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus
15. Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid-induced seizures
16. Outcome in neonates with convulsions treated in an intensive care unit
17. Ischemia changes the coexpression of somatostatin and neuropeptide Y in hippocampal interneurons
18. Persistent worsening of stroke sequelae after delayed seizures
19. The intraischemic and early reperfusion changes of protein synthesis in the rat brain. eIF-2 alpha kinase activity and role of initiation factors eIF-2 alpha and eIF-4E
20. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage
21. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
22. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury
23. Neuropeptide Y-Y1 receptor antisense oligodeoxynucleotide increases the infarct volume after middle cerebral artery occlusion in rats
24. Time-course of neuropeptide changes in peri-ischemic zone and amygdala following focal ischemia in rats
25. The anatomy of neuropeptide-Y-containing neurons in rat brain
26. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor
27. Acute focal ischemia-induced alterations in MAP2 immunostaining: Description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury
28. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohisto-chemical analysis
29. Global brain ischemia and reperfusion: Modifications in eukaryotic initiation factors associated with inhibition of translation initiation
30. Effect of brain ischemia and reperfusion on the localization of phosphorylated eukaryotic initiation factor 2 alpha
31. Rapid colorimetric assay for cell growth and survival: Modification to the tetrazolium dye procedure giving improved sensitivity and reliability
32. Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures
33. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival
34. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
35. Neuropeptide Y inhibits potassiuna-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro
36. Effects of transient forebrain ischemia on peptidergic neurons and astroglial cells: Evidence For recovery of peptide immunoreactivities in neocortex and striatum but not hippocampal formation
37. Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep
38. BDNF protects the neonatal brain from hypoxic-ischemic injury In vivo via the ERK pathway
39. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia
40. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase
41. Effect of neonatal hypoxia-ischemia on nigro-striatal dopamine receptors and on striatal neuropeptide Y, dynorphin A and substance P concentrations in rats
42. Neurotrophin signal transduction in the nervous system
43. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striaturn
44. Epileptic seizures in acute stroke
45. Brain-derived neurotrophic factor prevents neuronal death and glial activation after global ischemia in the rat
46. Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage-immunohistochemical investigation of dendritic damage
47. Trks: Signal transduction and intracellular pathways
48. Potentiated necrosis of cultured cortical neurons by neurotrophins
49. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis
50. Suppression of protein synthesis in the reperfused brain
51. Brain ischemia and reperfusion activates the eukaryotic initiation factor 2α kinase, PERK
52. A simple, rapid, and sensitive DNA assay procedure
53. Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats
54. Neonatal seizures associated with cerebral lesions shown by magnetic resonance imaging
55. Neonatal seizures associated with cerebral lesions shown by magnetic resonance imaging
56. Ischemic cell death in brain neurons
57. Forskolin and phorbol ester stimulation of neuropeptide Y (NPY) production and secretion by aggregating fetal brain cells in culture: Evidence for regulation of NPY biosynthesis at transcriptional and posttranscriptional levels
58. An early and transient period of protein synthesis is required for induction of neuropeptide Y-mRNA by phorbol ester and forskolin in aggregate cultures of fetal brain cells
59. Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat
60. Role of the Y5 neuropeptide Y receptor in limbic seizures
61. MAP2, synaptophysin immunostaining in rat brain and behavioral modifications after cerebral postischemic reperfusion
62. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain
63. Transcriptional regulation of the human neuropeptide Y gene by nerve growth factor
64. Time-dependent changes of vasoactive substances in rat cerebral ischemia
65. Glucose deprivation neuronal injury in cortical culture
66. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons
67. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function
68. Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats
69. Neuropeptide Y and somatostatin immunoreactivy in the rat hippocampus after moderate hypoxia
70. Significance of seizures in infants weighing less than 2,500 grams
71. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway
72. Cell death in primary cultures of mouse neurons and astrocytes during exposure to and 'recovery' from hypoxia, substrate deprivation and simulated ischemia
73. trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor
74. Neuropeptide Y: Emerging evidence for a functional role is seizure modulation
75. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect
76. Postischemic seizures and necrotizing ischemic brain damage: Neuroprotective effect of postischemic diazepam and insulin
77. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat
78. Activated transcription of the human neuropeptide Y gene in differentiating SH-SY5Y neuroblastoma cells is dependent on transcription factors AP-1, AP-2α, and NGFI
79. Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cγ and Shc binding sites on its receptor, TrkB
80. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5- like receptors
81. Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons
82. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor